MyFinsight
Home
Blog
About
Back
Income Statement
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)
source: myfinsight.com
Net loss
-$613,933
(6.97%↑ Y/Y)
Interest income
$4,664
(-86.98%↓ Y/Y)
Loss from operations
-$618,597
(11.09%↑ Y/Y)
Total expenses
$618,597
(-11.09%↓ Y/Y)
General and
administrative
$395,033
(6.72%↑ Y/Y)
Research and development
$223,564
(-31.34%↓ Y/Y)
Back